Cargando…
Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform
Lujo virus (LUJV), a highly pathogenic arenavirus, was first identified in 2008 in Zambia. To aid the identification of effective therapeutics for LUJV, we developed a recombinant reporter virus system, confirming reporter LUJV comparability with wild-type virus and its utility in high-throughput an...
Autores principales: | Welch, Stephen R., Spengler, Jessica R., Genzer, Sarah C., Chatterjee, Payel, Flint, Mike, Bergeron, Éric, Montgomery, Joel M., Nichol, Stuart T., Albariño, César G., Spiropoulou, Christina F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310135/ https://www.ncbi.nlm.nih.gov/pubmed/34203149 http://dx.doi.org/10.3390/v13071255 |
Ejemplares similares
-
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2018) -
Severe Hemorrhagic Fever in Strain 13/N Guinea Pigs Infected with Lujo Virus
por: Bird, Brian H., et al.
Publicado: (2012) -
25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2016) -
Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin
por: Bergeron, Éric, et al.
Publicado: (2015) -
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
por: Flint, Mike, et al.
Publicado: (2019)